Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

B.B. Koolen; M.J. Vrancken Peeters; J. Wesseling; E.H. Lips; W.V. Vogel; T.S. Aukema; E. van Werkhoven; K.G.A. Gilhuijs; S. Rodenhuis; E.J. Rutgers; R.A. Valdes Olmos

doi:10.1007/s00259-012-2211-z

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

B.B. Koolen, M.J. Vrancken Peeters, J. Wesseling, E.H. Lips, W.V. Vogel, T.S. Aukema, E. van Werkhoven, K.G.A. Gilhuijs, S. Rodenhuis, E.J. Rutgers, R.A. Valdes Olmos

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1830-1838
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	39
Issue number	12
DOIs	https://doi.org/10.1007/s00259-012-2211-z
Publication status	Published - Dec 2012

Keywords

Breast cancer
PET/CT
Subtype
Prognosis
Characteristics
Response monitoring

Access to Document

10.1007/s00259-012-2211-z

http://www.ncbi.nlm.nih.gov/pubmed/22895862

Cite this

Koolen, B. B., Vrancken Peeters, M. J., Wesseling, J., Lips, E. H., Vogel, W. V., Aukema, T. S., van Werkhoven, E., Gilhuijs, K. G. A., Rodenhuis, S., Rutgers, E. J., & Valdes Olmos, R. A. (2012). Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy. European Journal of Nuclear Medicine and Molecular Imaging, 39(12), 1830-1838. https://doi.org/10.1007/s00259-012-2211-z

@article{ab966863456d4d9c834f852b4c0f0276,

title = "Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy",

keywords = "Breast cancer, PET/CT, Subtype, Prognosis, Characteristics, Response monitoring",

author = "B.B. Koolen and {Vrancken Peeters}, M.J. and J. Wesseling and E.H. Lips and W.V. Vogel and T.S. Aukema and {van Werkhoven}, E. and K.G.A. Gilhuijs and S. Rodenhuis and E.J. Rutgers and {Valdes Olmos}, R.A.",

year = "2012",

month = dec,

doi = "10.1007/s00259-012-2211-z",

language = "English",

volume = "39",

pages = "1830--1838",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "12",

}

Koolen, BB, Vrancken Peeters, MJ, Wesseling, J, Lips, EH, Vogel, WV, Aukema, TS, van Werkhoven, E, Gilhuijs, KGA, Rodenhuis, S, Rutgers, EJ & Valdes Olmos, RA 2012, 'Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy', European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 12, pp. 1830-1838. https://doi.org/10.1007/s00259-012-2211-z

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy. / Koolen, B.B.; Vrancken Peeters, M.J.; Wesseling, J. et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, No. 12, 12.2012, p. 1830-1838.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

AU - Koolen, B.B.

AU - Vrancken Peeters, M.J.

AU - Wesseling, J.

AU - Lips, E.H.

AU - Vogel, W.V.

AU - Aukema, T.S.

AU - van Werkhoven, E.

AU - Gilhuijs, K.G.A.

AU - Rodenhuis, S.

AU - Rutgers, E.J.

AU - Valdes Olmos, R.A.

PY - 2012/12

Y1 - 2012/12

KW - Breast cancer

KW - PET/CT

KW - Subtype

KW - Prognosis

KW - Characteristics

KW - Response monitoring

U2 - 10.1007/s00259-012-2211-z

DO - 10.1007/s00259-012-2211-z

M3 - Article

SN - 1619-7070

VL - 39

SP - 1830

EP - 1838

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 12

ER -